Pneumoviruses and Metapneumoviruses

Total Page:16

File Type:pdf, Size:1020Kb

Pneumoviruses and Metapneumoviruses Pneumoviruses and Metapneumoviruses Edited by Helene F. Rosenberg & Joseph B. Domachowske Printed Edition of the Special Issue Published in Viruses www.mdpi.com/journal/viruses Helene F. Rosenberg and Joseph B. Domachowske (Eds.) Pneumoviruses and Metapneumoviruses This book is a reprint of the special issue that appeared in the online open access journal Viruses (ISSN 1999-4915) in 2013 (available at: http://www.mdpi.com/journal/viruses/special_issues/pneumoviruses_metapneumoviruses). Guest Editors Helene F. Rosenberg National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, MD, USA Joseph B. Domachowske SUNY Upstate Medical University Syracuse, NY, USA Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Production Editor Matthias Burkhalter 1. Edition 2013 MDPI • Basel • Beijing ISBN 978-3-03842-049-1 © 2013 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. Table of Contents Preface ....................................................................................................................................................vii 1. General Review Lenneke E. M. Haas, Steven F. T. Thijsen, Leontine van Elden and Karen A. Heemstra Human Metapneumovirus in Adults......................................................................................................... 1 Reprinted from Viruses 2013, 5(1), 87-110; doi:10.3390/v501008 http://www.mdpi.com/1999-4915/5/1/87 2. Experimental Models and Methods Rachel J. Derscheid and Mark R. Ackermann Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection .............................................. 26 Reprinted from Viruses 2012, 4(10), 2359-2378; doi:10.3390/v4102359 http://www.mdpi.com/1999-4915/4/10/2359 Randy E. Sacco, Jodi L. McGill, Mitchell V. Palmer, John D. Lippolis, Timothy A. Reinhardt and Brian J. Nonnecke Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants ........................................................................................................................................ 47 Reprinted from Viruses 2012, 4(12), 3731-3753; doi:10.3390/v4123731 http://www.mdpi.com/1999-4915/4/12/3731 Kimberly D. Dyer, Katia E. Garcia-Crespo, Stephanie Glineur, Joseph B. Domachowske and Helene F. Rosenberg The Pneumonia Virus of Mice (PVM) Model of Acute Respiratory Infection...................................... 70 Reprinted from Viruses 2012, 4(12), 3494-3510; doi:10.3390/v4123494 http://www.mdpi.com/1999-4915/4/12/3494 Sumana Fathima, Bonita E. Lee, Jennifer May-Hadford, Shamir Mukhi and Steven J. Drews Use of an Innovative Web-Based Laboratory Surveillance Platform to Analyze Mixed Infections Between Human Metapneumovirus (hMPV) and Other Respiratory Viruses Circulating in Alberta (AB), Canada (2009–2012) ................................................................................ 88 Reprinted from Viruses 2012, 4(11), 2754-2765; doi:10.3390/v4112754 http://www.mdpi.com/1999-4915/4/11/2754 iv 3. Epidemiology and Virus Evolution Luiz Gustavo Araujo Gardinassi, Paulo Vitor Marques Simas, Deriane Elias Gomes, Caroline Measso do Bonfim, Felipe Cavassan Nogueira, Gustavo Rocha Garcia, Claudia Márcia Aparecida Carareto, Paula Rahal and Fátima Pereira de Souza Diversity and Adaptation of Human Respiratory Syncytial Virus Genotypes Circulating in Two Distinct Communities: Public Hospital and Day Care Center ..................................................... 100 Reprinted from Viruses 2012, 4(11), 2432-2447; doi:10.3390/v4112432 http://www.mdpi.com/1999-4915/4/11/2432 Rosa Elena Sarmiento-Silva, Yuko Nakamura-Lopez and Gilberto Vaughan Epidemiology, Molecular Epidemiology and Evolution of Bovine Respiratory Syncytial Virus ....... 117 Reprinted from Viruses 2012, 4(12), 3452-3467; doi:10.3390/v4123452 http://www.mdpi.com/1999-4915/4/12/3452 Penelope Adamson, Sutthiwan Thammawat, Gamaliel Muchondo, Tania Sadlon and David Gordon Diversity in Glycosaminoglycan Binding Amongst hMPV G Protein Lineages ................................. 134 Reprinted from Viruses 2012, 4(12), 3785-3803; doi:10.3390/v4123785 http://www.mdpi.com/1999-4915/4/12/3785 4. Viral Pathogenesis and Cellular Responses Peter Mastrangelo and Richard G. Hegele RSV Fusion: Time for a New Model ................................................................................................... 154 Reprinted from Viruses 2013, 5(3), 873-885; doi:10.3390/v5030873 http://www.mdpi.com/1999-4915/5/3/873 Evelyn Rivera-Toledo and Beatríz Gómez Respiratory Syncytial Virus Persistence in Macrophages Alters the Profile of Cellular Gene Expression ............................................................................................................................................ 167 Reprinted from Viruses 2012, 4(12), 3270-3280; doi:10.3390/v4123270 http://www.mdpi.com/1999-4915/4/12/3270 Jonas Bystrom, Nasra Al-Adhoubi, Mohammed Al-Bogami, Ali S. Jawad and Rizgar A. Mageed Th17 Lymphocytes in Respiratory Syncytial Virus Infection.............................................................. 178 Reprinted from Viruses 2013, 5(3), 777-791; doi:10.3390/v5030777 http://www.mdpi.com/1999-4915/5/3/777 v Deepthi Kolli, Xiaoyong Bao and Antonella Casola Human Metapneumovirus Antagonism of Innate Immune Responses ................................................ 193 Reprinted from Viruses 2012, 4(12), 3551-3571; doi:10.3390/v4123551 http://www.mdpi.com/1999-4915/4/12/3551 Reagan G. Cox and John V. Williams Breaking In: Human Metapneumovirus Fusion and Entry................................................................... 215 Reprinted from Viruses 2013, 5(1), 192-210; doi:10.3390/v5010192 http://www.mdpi.com/1999-4915/5/1/192 Ellen R. T. Watkiss, Pratima Shrivastava, Natasa Arsic, Susantha Gomis and Sylvia van Drunen Littel-van den Hurk Innate and Adaptive Immune Response to Pneumonia Virus of Mice in a Resistant and a Susceptible Mouse Strain ..................................................................................................................... 235 Reprinted from Viruses 2013, 5(1), 295-320; doi:10.3390/v5010295 http://www.mdpi.com/1999-4915/5/1/295 Elske van den Berg, Job B.M. van Woensel and Reinout A. Bem Apoptosis in Pneumovirus Infection .................................................................................................... 261 Reprinted from Viruses 2013, 5(1), 406-422; doi:10.3390/v5010406 http://www.mdpi.com/1999-4915/5/1/406 Antonieta Guerrero-Plata Dendritic Cells in Human Pneumovirus and Metapneumovirus Infections ......................................... 278 Reprinted from Viruses 2013, 5(6), 1553-1570; doi:10.3390/v5061553 http://www.mdpi.com/1999-4915/5/6/1553 5. Vaccine Development Rajeev Rudraraju, Bart G. Jones, Robert Sealy, Sherri L. Surman and Julia L. Hurwitz Respiratory Syncytial Virus: Current Progress in Vaccine Development............................................ 297 Reprinted from Viruses 2013, 5(2), 577-594; doi:10.3390/v5020577 http://www.mdpi.com/1999-4915/5/2/577 Preface This volume of Viruses includes seventeen independent contributions that focus on the biology of pneumovirus and metapneumovirus respiratory virus pathogens. As a group, these are all pathogens of the family Paramyxoviridae, which are enveloped viruses with non-segmented single stranded RNA genomes that cause acute infections of the upper and lower respiratory tract. Among the pneumovirus pathogens, first and foremost is the human respiratory syncytial virus (HRSV; genus, pneumovirus). HRSV is the leading cause of lower respiratory tract infection in infants and children, and is an emerging pathogen of the elderly (reviewed in [1]). Current management for HRSV disease includes prophylaxis with humanized monoclonal antibody, a regimen available to infants identified as high- risk only (i.e. those born prematurely, with bronchopulmonary dysplasia, immunodeficiency or congenital heart disease). At this time, there are no vaccines available to prevent HRSV infection. Two contributions to this volume describe interesting and relatively novel experimental models, including a perinatal lamb model (Dersheid and Ackermann) and neonatal calf model of HRSV infection (Nonnecke and colleagues), both drawing important parallels to infection in human infants. In another contribution, Pereira de Souza and colleagues provide an update on circulating HRSV (G-gene based) genotypes in São José do Rio Preto, Brazil. Also included are several studies focused on HRSV basic biology and pathogenesis including receptor-based fusion (Mastrangelo and Hegele), gene expression in macrophages (Rivera-Toledo and Gomez) and interactions with Th17 lymphocytes (Mageed and colleagues). Finally, Hurwitz and colleagues have contributed a crucial update on current progress towards development of a safe and effective vaccine for prevention of this HRSV infection. Bovine RSV (BRSV) is a pathogen of considerable veterinary importance. Similar to the clinical impact of HRSV, BRSV infects cattle worldwide, with the
Recommended publications
  • Gut Microbiota Beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
    International Journal of Molecular Sciences Review Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD Mario Matijaši´c 1,* , Tomislav Meštrovi´c 2, Hana Cipˇci´cPaljetakˇ 1, Mihaela Peri´c 1, Anja Bareši´c 3 and Donatella Verbanac 4 1 Center for Translational and Clinical Research, University of Zagreb School of Medicine, 10000 Zagreb, Croatia; [email protected] (H.C.P.);ˇ [email protected] (M.P.) 2 University Centre Varaždin, University North, 42000 Varaždin, Croatia; [email protected] 3 Division of Electronics, Ruđer Boškovi´cInstitute, 10000 Zagreb, Croatia; [email protected] 4 Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia; [email protected] * Correspondence: [email protected]; Tel.: +385-01-4590-070 Received: 30 January 2020; Accepted: 7 April 2020; Published: 11 April 2020 Abstract: The human microbiota is a diverse microbial ecosystem associated with many beneficial physiological functions as well as numerous disease etiologies. Dominated by bacteria, the microbiota also includes commensal populations of fungi, viruses, archaea, and protists. Unlike bacterial microbiota, which was extensively studied in the past two decades, these non-bacterial microorganisms, their functional roles, and their interaction with one another or with host immune system have not been as widely explored. This review covers the recent findings on the non-bacterial communities of the human gastrointestinal microbiota and their involvement in health and disease, with particular focus on the pathophysiology of inflammatory bowel disease. Keywords: gut microbiota; inflammatory bowel disease (IBD); mycobiome; virome; archaeome; eukaryotic parasites 1. Introduction Trillions of microbes colonize the human body, forming the microbial community collectively referred to as the human microbiota.
    [Show full text]
  • Rational Design of Human Metapneumovirus Live Attenuated Vaccine Candidates by Inhibiting Viral Messenger RNA Cap Methyltransferase
    Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral messenger RNA cap methyltransferase DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Yu Zhang The Graduate Program in Food Science and Technology The Ohio State University 2014 Dissertation Committee: Dr. Jianrong Li, advisor Dr. Melvin Pascall Dr. Stefan Niewiesk Dr. Tracey Papenfuss Copyrighted by Yu Zhang 2014 Abstract Human metapneumovirus (hMPV) is a newly discovered paramyxovirus, first identified in 2001 in the Netherlands in infants and children with acute respiratory tract infections. Soon after its discovery, hMPV was recognized as a globally prevalent pathogen. Epidemiological studies suggest that 5 to 15% of all respiratory tract infections in infants and young children are caused by hMPV, a proportion second only to that of human respiratory syncytial virus (hRSV). Despite major efforts, there are no therapeutics or vaccines available for hMPV. In the last decade, approaches to generate vaccines employing viral proteins or inactivated vaccines have failed either due to a lack of immunogenicity or the potential for causing enhanced pulmonary disease upon natural infection with the same virus. In contrast to inactivated vaccines, enhanced lung diseases have not been observed for candidate live attenuated hMPV vaccines. Thus, a living attenuated vaccine is the most promising vaccine candidate for hMPV. However, it has been a challenge to identify an hMPV vaccine strain that has an optimal balance between attenuation and immunogenicity. In addition, hMPV grows poorly in cell culture and the growth is trypsin-dependent.
    [Show full text]
  • Human Metapneumovirus Pcr
    Lab Dept: Microbiolgy/Virology Test Name: HUMAN METAPNEUMOVIRUS PCR General Information Lab Order Codes: HMPV Synonyms: hMPV PCR; Metapneumovirus PCR; Respiratory viruses, human Metapneumovirus (hMPV) PCR only CPT Codes: 87798 – Amplified probe technique, each organism Test Includes: Detection of human metapneumovirus in patients exhibiting symptoms of acute upper and /or lower respiratory tract infections by RT-PCR (Reverse Transcription Polymerase Chain Reaction. Logistics Lab Testing Sections: Sendout Outs – Microbiology/Virology Phone Number: MIN Lab: 612-813-5866 STP Lab: 651-220-6655 Referred to: Mayo Medical Laboratories (FHMPV) and forwarded to Focus Diagnostics (49200) Test Availability: Specimens accepted daily, 24 hours Turnaround Time: 1 – 5 days Special Instructions: Requisition must state specific site of specimen and date/time of collection. Specimen Specimen Type: Bronchoalveolar lavage (BAL) specimens; nasopharyngeal aspirates; NP swabs (V-C-M medium green cap or equivalent UTM) in 3 mL M4 media. Container: Sterile screw cap container; swab transport media; viral transport media Volume: 0.7 mL nasal aspirates or BAL; NP swabs Collection: Nasal Aspiration 1. Prepare suction set up on low to medium suction. 2. Wash hands. 3. Put on protective barriers (e.g., gloves, gown, mask). 4. Place child supine and obtain assistant to hold child during procedure. 5. Attach luki tube to suction tubing and #6 French suction catheter. 6. Insert catheter into nostril and pharynx without applying suction. 7. Apply suction as catheter is withdrawn. 8. If necessary, suction 0.5 – 1 mL of normal saline through catheter in order to clear the catheter and increase the amount of specimen in the luki tube.
    [Show full text]
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • The Influence of Temperature and Rainfall in the Human Viral Infections a Influência Da Temperatura E Índice Pluviométrico Nas Infecções Virais Humanas
    Volume 1, Número 1, 2019 The influence of temperature and rainfall in the human viral infections A influência da temperatura e índice pluviométrico nas infecções virais humanas VIDAL, L. R. R.1*; PEREIra, L. A.1; DEBUR, M. C.2; RABONI, S. M.1,3; NOGUEIra, M. B.1,4; CavaLLI B.1; ALMEIDA, S. M.1,5 1 Virology Laboratory, Hospital de Clínicas da Universidade Federal do Paraná; 2 Molecular Biology Laboratory, Laboratório Central do Estado, Secretaria de Saúde do Estado do Paraná, 3 Departamento de Saúde Comunitária and Programa de Pós Graduação em Medicina Interna Infectious Diseases Department, Universidade Federal do Paraná; 4 Departamento de Análises Clínicas and Programa de Pós Graduação em Tocoginecologia, Universidade Federal do Paraná; *Corresponding Author: Luine Rosele Renaud Vidal Virology Laboratory, Setor de Ciências da Saúde, UFPR, Rua Padre Camargo, 280. Bairro Alto da Glória, CEP: 80.060-240 Phone number: +55 41 3360 7974 | E-mail: [email protected] DOI: https://doi.org/10.29327/226760.1.1-2 Recebido em 11/01/2019; Aceito em 15/01/19 Abstract It is well described by many authors the occurrence of viruses outbreaks that occurs annually at the same time. Epidemiological studies could generate important information about seasonality and its relation to outbreaks, population fluctuations, geographical variations, seasonal environmental. The purpose of this study was to show the influence of temperature and rainfall on the main viral diseases responsible for high rates of morbidity and mortality. Data were collected from samples performed at the Virology Laboratory of the Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR), which is a university tertiary hospital, in the period of 2003 to 2013.
    [Show full text]
  • E517.Full.Pdf
    Life-Threatening Human Metapneumovirus Pneumonia Requiring Extracorporeal Membrane Oxygenation in a Preterm Infant Rolando Ulloa-Gutierrez, MD*; Peter Skippen, FRCPC‡; Anne Synnes, MDCM, MHSc§; Michael Seear, MD‡; Nathalie Bastien, PhD࿣; Yan Li, PhD࿣; and John C Forbes, MBChB* ABSTRACT. We present the first report in the literature the previous 12 hours, he had developed poor feeding, lethargy, of a child with human metapneumovirus pneumonia increasing cough, respiratory distress, and cyanosis. No history of who required extracorporeal membrane oxygenation for fever was documented. The patient’s father and 2 young siblings survival. This was a 3-month-old premature boy from each had experienced an uncomplicated, brief, nonfebrile, upper respiratory tract infection in the previous 3 weeks. British Columbia, Canada, who developed severe respi- This infant was born at 27 weeks of gestation (through cesarean ratory failure, experienced failure of high-frequency os- section, because of preterm labor), with a birth weight of 1200 g cillatory mechanical ventilation, and required extracor- and Apgar scores of 1 and 8 at 1 and 5 minutes, respectively. He poreal membrane oxygenation support for 10 days. This developed hyaline membrane disease and had a persistently case illustrates the importance of including this newly patent ductus arteriosus, which was treated with indomethacin. discovered pathogen among the causes of childhood Mechanical ventilation was required for 3 weeks. The patient was pneumonia. Pediatrics 2004;114:e517–e519. URL: www. discharged from the hospital at 2 months of age. Palivizumab was pediatrics.org/cgi/doi/10.1542/peds.2004-0345; human administered at 1 and 2 months of age, and the patient was metapneumovirus, viral pneumonia, prematurity, respira- scheduled to receive a third dose when he became ill.
    [Show full text]
  • Human Metapneumovirus Circulation in the United States, 2008 to 2014 Amber K
    Human Metapneumovirus Circulation in the United States, 2008 to 2014 Amber K. Haynes, MPH, a Ashley L. Fowlkes, MPH, b Eileen Schneider, MD,a Jeffry D. Mutuc, MPH,a Gregory L. Armstrong, MD, c Susan I. Gerber, MDa BACKGROUND: Human metapneumovirus (HMPV) infection causes respiratory illness, including abstract bronchiolitis and pneumonia. However, national HMPV seasonality, as it compares with respiratory syncytial virus (RSV) and influenza seasonality patterns, has not been well described. METHODS: Hospital and clinical laboratories reported weekly aggregates of specimens tested and positive detections for HMPV, RSV, and influenza to the National Respiratory and Enteric Virus Surveillance System from 2008 to 2014. A season was defined as consecutive weeks with ≥3% positivity for HMPV and ≥10% positivity for RSV and influenza during a surveillance year (June through July). For each virus, the season, onset, offset, duration, peak, and 6-season medians were calculated. RESULTS: Among consistently reporting laboratories, 33 583 (3.6%) specimens were positive for HMPV, 281 581 (15.3%) for RSV, and 401 342 (18.2%) for influenza. Annually, 6 distinct HMPV seasons occurred from 2008 to 2014, with onsets ranging from November to February and offsets from April to July. Based on the 6-season medians, RSV, influenza, and HMPV onsets occurred sequentially and season durations were similar at 21 to 22 weeks. HMPV demonstrated a unique biennial pattern of early and late seasonal onsets. RSV seasons (onset, offset, peak) were most consistent and occurred before HMPV seasons. There were no consistent patterns between HMPV and influenza circulations. CONCLUSIONS: HMPV circulation begins in winter and lasts until spring and demonstrates distinct seasons each year, with the onset beginning after that of RSV.
    [Show full text]
  • Metapneumovirus
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository Metapneumovirus determinants of host range and replication Miranda de Graaf ISBN: 978-90-9023746-6 The research described in this thesis was conducted at the Department of Virology of Erasmus MC, Rotterdam, The Netherlands, with financial support from the framework five grant “Hammocs” from the European Union and MedImmune Vaccines, USA. Printing of this thesis was financially supported by: Vironovative B.V., Viroclinics B.V., Greiner Bio-One. Cover art by Rosanne van der Meer and Miranda de Graaf Cartoons by Dirk-Jan de Graaf (p 61 and 143) Layout design by Aukje van Meeteren Printed by PrintPartners Ipskamp B.V Metapneumovirus determinants of host range and replication Metapneumovirus determinanten van gastheerspecificiteit en replicatie Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de rector magnificus Prof.dr. S.W.J. Lamberts en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op donderdag 15 januari 2009 om 13.30 uur door: Miranda de Graaf geboren te Bergen (N.H.) Promotiecommissie Promotoren: Prof.dr. R.A.M. Fouchier Prof.dr. A.D.M.E. Osterhaus Overige leden: Prof.dr. A. van Belkum Prof.dr. M.P.G. Koopmans Prof.dr. B.K. Rima CONTENTS Page Chapter 1. General Introduction 1 Chapter 2. Recovery of human metapneumovirus genetic lineages A and B from 17 cloned cDNA Journal of Virology, 2004 Chapter 3. An improved plaque reduction virus neutralization assay for human 33 metapneumovirus Journal of Virological Methods, 2007 Chapter 4.
    [Show full text]
  • A Report of Two Cases of Human Metapneumovirus Infection in Pregnancy Involving Superimposed Bacterial Pneumonia and Severe Respiratory Illness
    Case Report J Clin Gynecol Obstet. 2019;8(4):107-110 A Report of Two Cases of Human Metapneumovirus Infection in Pregnancy Involving Superimposed Bacterial Pneumonia and Severe Respiratory Illness Jordan P. Emonta, c, Kathleen S. Chunga, Dwight J. Rousea, b Abstract tion (URI) [2]. In a literature search on PubMed of “human metapneu- Human metapneumovirus (HMPV) is a cause of mild to severe res- movirus AND pregnant” and “human metapneumovirus AND piratory viral infection. There are few descriptions of infection with pregnancy”, we identified two case reports of severe HMPV HMPV in pregnancy. We present two cases of HMPV infection occur- infection in pregnant women in the USA, and one descrip- ring in pregnancy, including a case of superimposed bacterial pneu- tive report of 25 pregnant women infected with mild HMPV monia in a pregnant woman after HMPV infection. In the first case, infection in rural Nepal. In a case by Haas et al (2012), a a 40-year-old woman at 29 weeks of gestation developed an asthma 24-year-old woman at 30 weeks of gestation developed res- exacerbation in association with a positive respiratory pathogen panel piratory failure requiring intensive care unit (ICU) admission (RPP) for HMPV infection. She was admitted to the intensive care secondary to HMPV pneumonia [3]. The case by Fuchs et al unit (ICU) for progressive respiratory failure. In the second case, a (2017) describes an 18-year-old patient at 36 weeks of gesta- 36-year-old woman at 31 weeks of gestation developed respiratory tion admitted to an intensive care unit (ICU) for acute respira- distress in association with a positive RPP for HMPV.
    [Show full text]
  • Arenaviridae Astroviridae Filoviridae Flaviviridae Hantaviridae
    Hantaviridae 0.7 Filoviridae 0.6 Picornaviridae 0.3 Wenling red spikefish hantavirus Rhinovirus C Ahab virus * Possum enterovirus * Aronnax virus * * Wenling minipizza batfish hantavirus Wenling filefish filovirus Norway rat hunnivirus * Wenling yellow goosefish hantavirus Starbuck virus * * Porcine teschovirus European mole nova virus Human Marburg marburgvirus Mosavirus Asturias virus * * * Tortoise picornavirus Egyptian fruit bat Marburg marburgvirus Banded bullfrog picornavirus * Spanish mole uluguru virus Human Sudan ebolavirus * Black spectacled toad picornavirus * Kilimanjaro virus * * * Crab-eating macaque reston ebolavirus Equine rhinitis A virus Imjin virus * Foot and mouth disease virus Dode virus * Angolan free-tailed bat bombali ebolavirus * * Human cosavirus E Seoul orthohantavirus Little free-tailed bat bombali ebolavirus * African bat icavirus A Tigray hantavirus Human Zaire ebolavirus * Saffold virus * Human choclo virus *Little collared fruit bat ebolavirus Peleg virus * Eastern red scorpionfish picornavirus * Reed vole hantavirus Human bundibugyo ebolavirus * * Isla vista hantavirus * Seal picornavirus Human Tai forest ebolavirus Chicken orivirus Paramyxoviridae 0.4 * Duck picornavirus Hepadnaviridae 0.4 Bildad virus Ned virus Tiger rockfish hepatitis B virus Western African lungfish picornavirus * Pacific spadenose shark paramyxovirus * European eel hepatitis B virus Bluegill picornavirus Nemo virus * Carp picornavirus * African cichlid hepatitis B virus Triplecross lizardfish paramyxovirus * * Fathead minnow picornavirus
    [Show full text]
  • Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic: a Repo
    Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada. November 2020 update This evidence synthesis was prepared for the Office of the Chief Dental Officer, based on a comprehensive review under contract by the following: Paul Allison, Faculty of Dentistry, McGill University Raphael Freitas de Souza, Faculty of Dentistry, McGill University Lilian Aboud, Faculty of Dentistry, McGill University Martin Morris, Library, McGill University November 30th, 2020 1 Contents Page Introduction 3 Project goal and specific objectives 3 Methods used to identify and include relevant literature 4 Report structure 5 Summary of update report 5 Report results a) Which patients are at greater risk of the consequences of COVID-19 and so 7 consideration should be given to delaying elective in-person oral health care? b) What are the signs and symptoms of COVID-19 that oral health professionals 9 should screen for prior to providing in-person health care? c) What evidence exists to support patient scheduling, waiting and other non- treatment management measures for in-person oral health care? 10 d) What evidence exists to support the use of various forms of personal protective equipment (PPE) while providing in-person oral health care? 13 e) What evidence exists to support the decontamination and re-use of PPE? 15 f) What evidence exists concerning the provision of aerosol-generating 16 procedures (AGP) as part of in-person
    [Show full text]
  • Accepted Version
    Article The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production BAMPI, Carole, et al. Abstract The cellular tail-interacting 47-kDa protein (TIP47) acts positively on HIV-1 and vaccinia virus production. We show here that TIP47, in contrast, acts as a restriction factor for Sendai virus production. This conclusion is supported by the occurrence of increased or decreased virus production upon its suppression or overexpression, respectively. Pulse-chase metabolic labeling of viral proteins under conditions of TIP47 suppression reveals an increased rate of viral protein synthesis followed by increased incorporation of viral proteins into virus particles. TIP47 is here described for the first time as a viral restriction factor that acts by limiting viral protein synthesis. Reference BAMPI, Carole, et al. The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production. Virus Research, 2013, vol. 173, no. 2, p. 354-63 DOI : 10.1016/j.virusres.2013.01.006 PMID : 23348195 Available at: http://archive-ouverte.unige.ch/unige:28890 Disclaimer: layout of this document may differ from the published version. 1 / 1 Virus Research 173 (2013) 354–363 Contents lists available at SciVerse ScienceDirect Virus Research journa l homepage: www.elsevier.com/locate/virusres The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production a a,b,1 c,d Carole Bampi , Anne-Sophie Gosselin Grenet , Grégory Caignard
    [Show full text]